Maybe this will be the answer to the long awaited news on financing....A coupon, voucher or whatever synonym you prefer for those words...maybe that PRV thingie gets split between Pfizer and Resverlogix.  If its $300 million divided in two they would have enough to retire the Citi-Bank loan with plenty left over to fund BETonMACE and BETonCVD.